ArticleCancers2025

Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre Study.

Umair Mahmood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.